Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/5135
Title: | Clinical Features and Lab Values of Patients with Chronic Hepatitis after Covid-19 |
Authors: | Зокирхўжаев Шерзод Яхъяевич, Паттахова Малика Хусановна |
Keywords: | Chronic hepatitis, Covid-19, Inflammation, Damage |
Issue Date: | 2022 |
Publisher: | Америка |
Abstract: | In scientific studies on the study of COVID-19, the researchers have reported that 14-53% of the cases showed signs of mild to moderate liver damage: increased levels of aminotransferases, hypoproteinemia, and an increase in prothrombin time. The severe course of the disease was associated with signs of liver damage. Exacerbation of pre-existing chronic liver disease leads to a more severe course of COVID-19 infection. The direct action of the SARS-CoV-2 virus can directly affect liver cells, as evidenced by the detection of increased expression of ACE-2 receptors in cholangiocytes [1,2]. Patients with advanced stages of chronic diffuse liver disease have a higher risk of infection due to immune disorders associated with the presence of cirrhosis [3]. The aim of the study was to study the clinical, functional and metabolic characteristics of patients with chronic hepatitis who had Covid-19. |
URI: | http://repository.tma.uz/xmlui/handle/1/5135 |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Зокирхужаев, Паттахова.pdf | Clinical Features and Lab Values of Patients with Chronic Hepatitis after Covid-19 | 154.58 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.